Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Trial Profile

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Risperidone; Serotonin uptake inhibitors
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2017 Planned End Date changed from 1 Dec 2006 to 1 Mar 2006.
    • 27 Aug 2007 Status changed from in progress to withdrawn. The study was withdrawn prior to recruitment due to failed recruitment efforts.
    • 10 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top